04:16 PM EST, 03/04/2025 (MT Newswires) -- Eliyahu Sharon Kalif, Executive Vice President, Chief Financial Officer, on February 28, 2025, sold 55,750 shares in Teva Pharmaceutical Industries ( TEVA ) for $903,462. Following the Form 4 filing with the SEC, Kalif has control over a total of 147,941 common shares of the company, with 147,941 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017025031946/xslF345X05/ownership.xml